The nuclear receptor NR4A1 induces a form of cell death dependent on autophagy in mammalian cells.
The control of cell death is a biological process essential for proper development, and for preventing devastating pathologies like cancer and neurodegeneration. On the other hand, autophagy regulation is essential for protein and organelle degradation, and its dysfunction is associated with overlapping pathologies like cancer and neurodegeneration, but also for microbial infection and aging. In the present report we show that two evolutionarily unrelated receptors--Neurokinin 1 Receptor (NK(1)R,) a G-protein coupled receptor, and Insulin-like Growth Factor 1 Receptor (IGF1R), a tyrosine kinase receptor--both induce non-apoptotic cell death with autophagic features and requiring the activity of the autophagic core machinery proteins PI3K-III, Beclin-1 and Atg7. Remarkably, this form of cell death occurs in apoptosis-competent cells. The signal transduction pathways engaged by these receptors both converged on the activation of the nuclear receptor NR4A1, which has previously been shown to play a critical role in some paradigms of apoptosis and in NK(1)R-induced cell death. The activity of NR4A1 was necessary for IGF1R-induced cell death, as well as for a canonical model of cell death by autophagy induced by the presence of a pan-caspase inhibitor, suggesting that NR4A1 is a general modulator of this kind of cell death. During cell death by autophagy, NR4A1 was transcriptionally competent, even though a fraction of it was present in the cytoplasm. Interestingly, NR4A1 interacts with the tumor suppressor p53 but not with Beclin-1 complex. Therefore the mechanism to promote cell death by autophagy might involve regulation of gene expression, as well as protein interactions. Understanding the molecular basis of autophagy and cell death mediation by NR4A1, should provide novel insights and targets for therapeutic intervention.
Developmental Genetics and Molecular Physiology Department, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, México.
Jimena
J
Bouzas-Rodríguez
Gabriela
G
Zárraga-Granados
Maria del Rayo
Mdel R
Sánchez-Carbente
Rocío
R
Rodríguez-Valentín
Xicotencatl
X
Gracida
Dámaris
D
Anell-Rendón
Luis
L
Covarrubias
Susana
S
Castro-Obregón
D001343:Autophagy; D061945:Caspase Inhibitors / Q000494:pharmacology; D016923:Cell Death / Q000502:physiology*; D057809:HEK293 Cells; D006801:Humans; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1 / Q000502:physiology*; D017526:Receptor, IGF Type 1 / Q000502:physiology
D061945:Caspase Inhibitors; C539821:NR4A1 protein, human; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1; D017526:Receptor, IGF Type 1